GNLY and alopecia areata: Oba et al.27 from our country, who examined serum granulysin levels before and after treatment with tofacitinib in patients with alopecia areata, found that the serum granulysin levels decreased significantly after treatment compared with baseline and that this molecule level was correlated with the immunological activity of alopecia areata.